Lawmakers continued criticizing Mylan NV over its EpiPen injector, with two leaders of the Senate Judiciary Committee calling for the Federal Trade Commission to review whether Mylan engaged in anticompetitive practices. Committee chairman Sen. Charles...

Source: Wall Street Journal November 08, 2016 00:51 UTC